Home page Home page

Rasitrio
aliskiren, amlodipine, hydrochlorothiazide

Package leaflet: information for the user


Rasitrio 150 mg/5 mg/12.5 mg film-coated tablets Aliskiren/amlodipine/hydrochlorothiazide


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Your doctor may need to change your dose and/or take other precautions if you are taking one of the following medicines:


Rasitrio with food and drink

You should take this medicine with a light meal once a day, preferably at the same time each day. You should not take this medicine with grapefruit juice.


Due to hydrochlorothiazide contained in Rasitrio, if you drink alcohol while on treatment with this medicine, you may have an increased feeling of dizziness on standing up, especially when getting up from a sitting position.


Pregnancy

Do not take this medicine if you are pregnant (see section Do not take Rasitrio). If you become pregnant while taking this medicine stop taking it immediately and talk to your doctor. If you think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Your doctor will normally advise you to stop taking Rasitrio before you become pregnant and will advise you to take another medicine instead of Rasitrio. Rasitrio is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if it is used after the third month of pregnancy.


Breast-feeding

Legemidlet er ikke lenger godkjent for salg

Tell your doctor if you are breast-feeding or about to start breast-feeding. Rasitrio is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed.


Driving and using machines

This medicine may make you feel dizzy and drowsy. If you experience this symptom, do not drive or use tools or machines.


  1. How to take Rasitrio


    Always take this medicine exactly as your doctor has told you and do not exceed the recommended dose. Check with your doctor or pharmacist if you are not sure.


    The usual dose of Rasitrio is one tablet a day.


    Method of administration

    Swallow the tablet whole with some water. You should take this medicine with a light meal once a day, preferably at the same time each day. You should not take this medicine together with grapefruit juice.


    If you take more Rasitrio than you should

    If you have accidentally taken too many Rasitrio tablets, talk to a doctor immediately. You may require medical attention.


    If you forget to take Rasitrio

    If you forget to take a dose of this medicine, take it as soon as you remember and then take the next dose at its usual time. If it is almost time for your next dose you should simply take the next tablet at the usual time. Do not take a double dose (two tablets at once) to make up for a forgotten tablet.

    Do not stop taking this medicine, even if you are feeling well (unless your doctor tells you to do so). People who have high blood pressure often do not notice any signs of the problem. Many may feel quite normal. It is very important that you take this medicine exactly as your doctor tells you to get the best results and reduce the risk of side effects. Keep your appointments with the doctor even if you are feeling well.


    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


  2. Possible side effects

    Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects reported for Rasitrio are:

    Common (may affect up to 1 in 10 people)

    • dizziness

    • low blood pressure

    • swelling of hands, ankles and feet (peripheral oedema).


      Tell your doctor immediately if you experience the following at the beginning of your treatment: Fainting and/or light-headedness linked to low blood pressure could occur at the beginning of treatment with Rasitrio. Patients 65 years of age or older are more susceptible to side effects related to low blood pressure. In clinical trials low blood pressure occurred more frequently in patients taking Rasitrio than those taking only dual combinations of aliskiren/amlodipine, aliskiren/hydrochlorothiazide or amlodipine/hydrochlorothiazide (see section 2).


      Legemidlet er ikke lenger godkjent for salg

      The following, possibly serious, side effects have been reported with medicines containing aliskiren, amlodipine or hydrochlorothiazide alone.


      Aliskiren

      Some side effects can be serious (frequency not known):

      A few patients have experienced these serious side effects (may affect up to 1 in 1,000 people). If any of the following occur, tell your doctor straight away:

    • Severe allergic reaction with symptoms such as rash, itching, swelling of face or lips or tongue, difficulty breathing, dizziness.

    • Nausea, loss of appetite, dark coloured urine or yellowing of skin and eyes (signs of liver disorder).


      Possible side effects

      Common (may affect up to 1 in 10 people)

    • diarrhoea

    • joint pain (arthralgia)

    • high level of potassium in the blood

    • dizziness.


      Uncommon (may affect up to 1 in 100 people)

    • skin rash (this may also be a sign of allergic reactions or angioedema – see “Rare” side effects below)

    • kidney problems including acute renal failure (severely decreased urine output)

    • swelling of hands, ankles or feet (peripheral oedema)

    • severe skin reactions (toxic epidermal necrolysis and/or oral mucosal reactions – red skin, blistering of the lips, eyes or mouth, skin peeling, fever)

    • low blood pressure

    • palpitations

    • cough

    • itching, itchy rash (urticaria)

    • increased liver enzymes.


      Rare (may affect up to 1 in 1,000 people)

    • severe allergic reaction (anaphylactic reaction)

    • allergic reactions (hypersensitivity)

    • angioedema (the symptoms of which can include difficulties in breathing or swallowing, rash, itching, hives or swelling of the face, hands and feet, eyes, lips and/or tongue, dizziness)

    • increased level of creatinine in the blood

    • red skin (erythema).


      Amlodipine

      In patients taking amlodipine alone, the following have been reported:

      Common (may affect up to 1 in 10 people)

    • sleepiness

    • dizziness

    • headache (especially at the beginning of treatment)

    • hot flushes

    • abdominal pain

    • nausea

    • ankle swelling

    • swelling

    • tiredness

    • palpitations (awareness of your heart beat).


      Legemidlet er ikke lenger godkjent for salg

      Uncommon (may affect up to 1 in 100 people)

    • insomnia

    • mood changes (including anxiety)

    • depression

    • trembling

    • disturbed sense of taste

    • sudden, temporary loss of consciousness

    • decreased skin sensitivity

    • tingling or numbness

    • vision disorder (including double vision)

    • ringing noise in ears

    • low blood pressure

    • breathlessness

    • runny nose

    • vomiting

    • stomach discomfort after meal

    • altered bowel habits (including diarrhoea and constipation)

    • dry mouth

    • hair loss

    • purple skin patches

    • skin discolouration

    • excessive sweating

    • itching; rash

    • generalised rash

    • joint pain

    • muscle pain

    • muscle cramps

    • back pain

    • urination disorders

    • urination at night

    • frequent urination

    • impotence

    • breast enlargement in men

    • chest pain

    • weakness

    • pain

    • feeling unwell

    • weight increase

    • weight decrease.


      Rare (may affect up to 1 in 1,000 people)

    • confusion.


      Very rare (may affect up to 1 in 10,000 people)

    • low level of white blood cells and blood platelets

    • allergic reaction with symptoms such as rash, itching, hives, difficulty breathing or swallowing, dizziness

    • high level of sugar in the blood

    • increased muscle stiffness and inability to stretch

    • sensation of numbness or tingling with sensation of burning in fingers and toes

    • heart attack

    • irregular heart beat

    • inflammation of blood vessels

    • cough

    • severe upper stomach pain

    • inflammation of the gastric lining

      Legemidlet er ikke lenger godkjent for salg

    • bleeding, tender or enlarged gums

    • inflammation of the liver

    • liver disorder which can occur together with yellow skin and eyes, or dark-coloured urine

    • abnormal liver function test

    • angioedema (difficulties in breathing, or swallowing, or swelling of the face, hands and feet, eyes, lips and/or tongue)

    • skin reaction with skin reddening and peeling, blistering of lips, eyes or mouth; dry skin, rash, itchy rash

    • skin rash with flaking or peeling; rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever

    • swelling mainly of the face and throat

    • increased sensitivity of the skin to sun.


      Hydrochlorothiazide

      In patients taking hydrochlorothiazide alone, the following have been reported, however the frequency cannot be estimated from the available data:

      Very common (may affect more than 1 in 10 people)

    • low level of potassium in the blood

    • increase of lipids in the blood.

      Common (may affect up to 1 in 10 people)

    • high level of uric acid in the blood

    • low level of magnesium in the blood

    • low level of sodium in the blood

    • dizziness, fainting on standing up

    • reduced appetite

    • nausea and vomiting

    • itchy rash and other types of rash

    • inability to achieve or maintain erection.


      Rare (may affect up to 1 in 1,000 people)

    • low level of blood platelets (sometimes with bleeding or bruising underneath the skin)

    • high level of calcium in the blood

    • high level of sugar in the blood

    • worsening of the diabetic metabolic state

    • sad mood (depression)

    • sleep disturbances

    • dizziness

    • headache

    • tingling or numbness

    • vision disorder

    • irregular heart beat

    • abdominal discomfort

    • constipation

    • diarrhoea

    • liver disorders which can occur together with yellow skin and eyes

      Legemidlet er ikke lenger godkjent for salg

    • increased sensitivity of skin to the sun

    • sugar in the urine.


      Very rare (may affect up to 1 in 10,000 people)

    • fever, sore throat or mouth ulcers, more frequent infections (lack or low level of white blood cells)

    • pale skin, tiredness, breathlessness, dark-coloured urine (haemolytic anaemia)

    • rash, itching, hives, difficulty breathing or swallowing, dizziness (hypersensitivity reactions)

    • confusion, tiredness, muscle twitching and spasm, rapid breathing (hypochloraemic alkalosis)

    • difficulty breathing with fever, coughing, wheezing, breathlessness (respiratory distress including pneumonitis and pulmonary oedema)

    • severe upper stomach pain (pancreatitis)

    • facial rash, joint pain, muscle disorder, fever (lupus erythematosus)

    • inflammation of blood vessels with symptoms such as rash, purplish-red spots, fever (vasculitis)

    • severe skin disease that causes rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever (toxic epidermal necrolysis).

      Not known (frequency cannot be estimated from the available data)

    • weakness

    • bruising and frequent infections (aplastic anaemia)

    • decrease in vision or pain in your eyes due to high pressure (possible signs of acute-angle closure glaucoma)

    • severe skin disease that causes rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever (erythema multiforme)

    • muscle spasm

    • severely decreased urine output (possible signs of renal disorder or renal failure), weakness (asthenia)

    • fever.


    If any of these affect you severely, tell your doctor. You may need to stop Rasitrio.


    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.


  3. How to store Rasitrio


    Keep this medicine out of the sight and reach of children.

    Do not use this medicine after the expiry date which is stated on the carton and blister after “EXP”. The expiry date refers to the last day of that month.

    Do not store above 30°C.

    Store Rasitrio tablets in the original package in order to protect from moisture and light.


    Legemidlet er ikke lenger godkjent for salg

    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


  4. Contents of the pack and other information What Rasitrio contains


Rasitrio is available in packs containing 14, 28, 56, 98 tablets in calendar blisters. It is also available in multi-packs of 98 tablets (2 packs of 49) in calendar blisters.


Rasitrio is available in packs containing 30 or 90 tablets in blisters.

Rasitrio is available in packs containing 56x1 tablet in perforated unit dose blister.

It is also available in multi-packs of 98x1 tablet (2 packs of 49x1) in perforated unit dose blister. Not all pack sizes may be available in your country.

Marketing Authorisation Holder Novartis Europharm Limited Wimblehurst Road

Horsham

West Sussex, RH12 5AB United Kingdom


Manufacturer

Novartis Farma S.p.A.

Via Provinciale Schito 131

I-80058 Torre Annunziata/NA Italy


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11

Lietuva

Novartis Pharma Services Inc. Tel: +370 5 269 16 50


България

Novartis Pharma Services Inc. Тел.: +359 2 489 98 28

Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11


Česká republika

Novartis s.r.o.

Tel: +420 225 775 111

Magyarország

Novartis Hungária Kft. Pharma Tel.: +36 1 457 65 00


Legemidlet er ikke lenger godkjent for salg

Danmark

Novartis Healthcare A/S Tlf: +45 39 16 84 00

Malta

Novartis Pharma Services Inc. Tel: +356 2122 2872


Deutschland

Novartis Pharma GmbH Tel: +49 911 273 0

Nederland

Novartis Pharma B.V. Tel: +31 26 37 82 111


Eesti

Novartis Pharma Services Inc. Tel: +372 66 30 810

Norge

Novartis Norge AS Tlf: +47 23 05 20 00


Ελλάδα

Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12

Österreich

Novartis Pharma GmbH Tel: +43 1 86 6570


España

Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00

Polska

Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888


France

Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00

Portugal

Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600


Hrvatska

Novartis Hrvatska d.o.o. Tel. +385 1 6274 220

România

Novartis Pharma Services Romania SRL Tel: +40 21 31299 01

Ireland

Novartis Ireland Limited Tel: +353 1 260 12 55

Slovenija

Novartis Pharma Services Inc. Tel: +386 1 300 75 50


Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika Novartis Slovakia s.r.o. Tel: +421 2 5542 5439


Italia

Novartis Farma S.p.A. Tel: +39 02 96 54 1

Suomi/Finland

Novartis Finland Oy

Puh/Tel: +358 (0)10 6133 200


Κύπρος

Novartis Pharma Services Inc. Τηλ: +357 22 690 690

Sverige

Novartis Sverige AB Tel: +46 8 732 32 00


Latvija

Novartis Pharma Services Inc. Tel: +371 67 887 070

United Kingdom

Novartis Pharmaceuticals UK Ltd. Tel: +44 1276 698370


This leaflet was last revised in


Legemidlet er ikke lenger godkjent for salg

a.europa.eu